Ifølge dets metabolisme forekommer metaboliske interaktioner med andre lægemidler højst sandsynligt ikke, selvom rivastigmin kan hæmme den butylkolinesterase- medierede metabolisme hos andre stoffer.
According to its metabolism, metabolic interactions with other medicinal products appear unlikely, although rivastigmine may inhibit the butyrylcholinesterase mediated metabolism of other substances.